Efficacy Study of Botox for Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01556971

Recruitment Status : Unknown

Verified March 2012 by Capital Clinical Research Associates, LLC.
Recruitment status was: Active, not recruiting

First Posted : March 19, 2012

Last Update Posted : March 19, 2012

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Capital Clinical Research Associates, LLC

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	June 2012
Estimated Study Completion Date :	June 2012

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Finzi E, Rosenthal NE. Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res. 2014 May;52:1-6. doi: 10.1016/j.jpsychires.2013.11.006. Epub 2013 Dec 1.

To Top